Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David A Jacob

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Open Forum Infectious Diseases|March 4, 2024
Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National Veterans Affairs CohortTing-Yi Chen, David A Jacob, John D Coppin, et al.
Biochemistry|May 21, 2011
Etoposide quinone is a redox-dependent topoisomerase II poisonDavid A Jacob, Susan L Mercer, Neil Osheroff, et al.
Joint Commission Journal on Quality and Patient Safety|September 30, 2018
Increased HCV Screening Yields Discordant Gains in Diagnoses Among Urban and Rural Veteran Populations in Texas: Results of a Statewide Quality Improvement InitiativeDaniel Wray, John D Coppin, Dawn Scott, et al.
Chemical Research in Toxicology|July 19, 2013
Etoposide catechol is an oxidizable topoisomerase II poisonDavid A Jacob, Elizabeth G Gibson, Susan L Mercer, et al.
Pharmacotherapy|April 9, 2022
Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort studyDanielle M Rumph, Craig M Straley, Jenny L Kolberg, et al.
Therapeutic Advances in Neurological Disorders|July 11, 2020
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populationsOlaf Stuve, Rick A Weideman, Danni M McMahan, et al.
The American Journal of Gastroenterology|January 14, 2022
The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health SystemNicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Plos One|May 2, 2023
User experience of a hepatitis c population management dashboard in the Department of Veterans AffairsVera Yakovchenko, David A Jacob, Shari S Rogal, et al.
Journal of the American Pharmacists Association : Japha|March 12, 2019
Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialistsHeather L Ourth, Julie A Groppi, Anthony P Morreale, et al.
The American Journal of Gastroenterology|November 30, 2020
Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With CirrhosisNicole J Kim, David A Jacob, George N Ioannou, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Open Forum Infectious Diseases|March 4, 2024
Risk of Hepatitis B Reactivation in Patients Receiving Ibrutinib: The National Veterans Affairs CohortTing-Yi Chen, David A Jacob, John D Coppin, et al.
Biochemistry|May 21, 2011
Etoposide quinone is a redox-dependent topoisomerase II poisonDavid A Jacob, Susan L Mercer, Neil Osheroff, et al.
Joint Commission Journal on Quality and Patient Safety|September 30, 2018
Increased HCV Screening Yields Discordant Gains in Diagnoses Among Urban and Rural Veteran Populations in Texas: Results of a Statewide Quality Improvement InitiativeDaniel Wray, John D Coppin, Dawn Scott, et al.
Chemical Research in Toxicology|July 19, 2013
Etoposide catechol is an oxidizable topoisomerase II poisonDavid A Jacob, Elizabeth G Gibson, Susan L Mercer, et al.
Pharmacotherapy|April 9, 2022
Impact of proton pump inhibitors on sustained virologic response in veterans treated with sofosbuvir/velpatasvir for chronic hepatitis C virus: A retrospective cohort studyDanielle M Rumph, Craig M Straley, Jenny L Kolberg, et al.
Therapeutic Advances in Neurological Disorders|July 11, 2020
Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populationsOlaf Stuve, Rick A Weideman, Danni M McMahan, et al.
The American Journal of Gastroenterology|January 14, 2022
The COVID-19 Pandemic Highlights Opportunities to Improve Hepatocellular Carcinoma Screening and Diagnosis in a National Health SystemNicole J Kim, Karine Rozenberg-Ben-Dror, David A Jacob, et al.
Plos One|May 2, 2023
User experience of a hepatitis c population management dashboard in the Department of Veterans AffairsVera Yakovchenko, David A Jacob, Shari S Rogal, et al.
Journal of the American Pharmacists Association : Japha|March 12, 2019
Increasing access for veterans with hepatitis C by enhancing use of clinical pharmacy specialistsHeather L Ourth, Julie A Groppi, Anthony P Morreale, et al.
The American Journal of Gastroenterology|November 30, 2020
Rates and Predictors of Undergoing Different Hepatocellular Carcinoma Screening Tests in Patients With CirrhosisNicole J Kim, David A Jacob, George N Ioannou, et al.
Pageof 2